Left Ventricular Dysfunction Pipeline Insights, 2018 Report - ResearchAndMarkets.com

DUBLIN--()--The "Left Ventricular Dysfunction - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'Left Ventricular Dysfunction - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Left Ventricular Dysfunction development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. Left Ventricular Dysfunction Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Left Ventricular Dysfunction

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Mentioned

  • Amgen Inc
  • Bayer AG
  • Capricor Therapeutics Inc
  • F. Hoffmann-La Roche Ltd
  • Innopharmax Inc
  • Les Laboratoires Servier SAS
  • Quantum Genomics SA
  • RedHill Biopharma Ltd

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/qtk8gd/left_ventricular?w=4.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs